BIO-Europe Spring Preview
EBD Group began with a straightforward mission: to connect biotech CEOs with pharma executives seeking partnerships on innovative products. However, the demand for collaboration quickly exceeded expectations, driving the rapid growth of EBD...
Introduction
Picky pharma prone to better proven partners amid dealmaking downturn
Successful mentorship between investors and CEOs hangs on respect
Tips toward a better presentation
Europe’s aversity to risk is why the US is ahead, say experts
Lessons and blessings: The Novo Nordisk way
Navigating the dealmaking landscape in 2024 and beyond
Biopharma commercialization readiness: what do leaders need to consider?
BIO-Europe Spring Preview eBook